Lise Larcher

18PUBLICATIONS
154CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Microbial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 26, 2026
Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

|Mar 25, 2026
Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in FANCM-Associated Fanconi Anemia.

Francesco Pegoraro, Lise Larcher, Rathana Kim

|Feb 27, 2026
MDM4 haploinsufficiency leads to p53-mediated bone marrow failure.

Richa Sharma, Senthil Velan Bhoopalan, Robert Meyer

|Oct 03, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers.

Marie-Charlotte Villy, Youenn Drouet, Lise Larcher

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Jul 11, 2024
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.

Jiarna R Zerella, Claire C Homan, Peer Arts

Pageof 3

Frequent Collaborators

7 joint publications

Lionel Adès

5 joint publications

Nicolas Duployez

5 joint publications

Marie Sébert

5 joint publications

Rathana Kim